Embleema

0 followers


Accelerating the availability of new treatments to the 350 million rare disease sufferers around the world.

Industries

Headquarters

Stage

Employees

Links

Robert Chu
CEO & Founder

Robert Chu

Collapse
Nicolas Schmidt
Chief Product Officer
Elaine E. Thompson
VP, Bioinformatics
Naira Stepanyan
Client Success Manager
Vahan Simonyan
Chief Scientist
Timothée EVAIN
VP of Engineering - Directeur Technique